Want to see ATHE full AI Analyst Report?
Ath434
Multiple System Atrophy
Phase II
Not Yet Recruiting
Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France
Jul 16, 2026
―
Ath434
Multiple System Atrophy
Phase II
Completed
A Biomarker Study of ATH434 in Participants With MSA
May 09, 2023
―
Ath434 Dose Level 1, Ath434 Dose Level 2
Multiple System Atrophy
Phase II
Completed
Study of ATH434 in Participants with Multiple System Atrophy
Oct 22, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Alterity Therapeutics Ltd (ATHE) have in its pipeline
ATHE is currently developing the following drugs: Ath434, Ath434, Ath434 Dose Level 1, Ath434 Dose Level 2. These drug candidates are in various stages of clinical development as the company works toward FDA approval.